Nemolizumab Rapidly Improves EASI, SCORAD Scores for Atopic Dermatitis
A post hoc analysis shows the investigative drug significantly improved atopic dermatitis symptoms versus placebo as soon as the first week into a phase 2 trial.
Source: hcplive.com